FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Azevedo, ZMA
   dos Santos, B
   Ramos, EG
   Salu, MD
   Caixeta, DMD
   Lima-Setta, F
   Jacques, ML
   da Fonseca, VM
   Pedroso, ER
   Moore, DCBC
AF Almeida de Azevedo, Zina Maria
   dos Santos Junior, Braulio
   Ramos, Eloane Goncalves
   Salu, Margarida dos Santos
   da Luz Caixeta, Daniella Mancino
   Lima-Setta, Fernanda
   Jacques, Melissa Lorena
   da Fonseca, Vania Mattos
   Pedroso, Elza Rosa
   Batalha Cox Moore, Daniella Campelo
TI The importance of bioelectrical impedance in the critical pediatric
   patient
SO CLINICAL NUTRITION
LA English
DT Article
DE Sepsis; Electric impedance; Child; Critical illness; Septic shock;
   Biomarkers
ID INFLAMMATORY RESPONSE SYNDROME; SEPSIS; CHILDREN; VALUES; VECTOR;
   DEFINITIONS; PARAMETERS; PROFILES; SHOCK; RISK
AB Background & aims: Sepsis is still a significant cause of death in the Intensive Care Unit and its early diagnosis is vital. Changes in cell permeability have been observed early in sepsis. Lower values of bioelectrical impedance (BIA) such as reactance adjusted by height (Xc/H) and phase angle (PA) have already been studied as a prognostic biomarker for many diseases and may indicate cell injury. BIA is a low cost, practical, noninvasive method that can be measured at bedside. This study investigated the utility of PA and Xc/H raw values in the pediatric critical care unit as predictors of progression to septic shock, as a clinical monitoring tool and to support the diagnosis of septic shock.
   Methods: We prospectively analyzed bioelectrical impedance in 145 children aged between one month and six years who were not in septic shock on admission to the intensive care unit Serial bioelectrical impedance analysis (BIA) measures were analyzed to determine the sensitivity and specificity of accurately identifying children who subsequently developed septic shock. Kaplan-Meier septic shock-free survival curves modeled by Xc/H and PA were done.
   Results: The free-septic shock survival curve analysis showed that patients with the lowest median values of Xc/H and PA were associated with the highest percentage of occurrence of septic shock (p = 0.0001 for Xc/H and <0.0006 for PA) and longest length of stay in the intensive care unit (p < 0.0011 for Xc/H and p < 0.004 for PA). Values of Xc/H below 48.63 Ohm/m at admission showed statistically significant odds ratio (OR) of 3.72 for developing septic shock any time during the hospitalization period, with a 87% sensitivity, 35% specificity and an area under the curve (AUC) of 0.62. The PA at admission did not show significant results. During hospitalization, patients with Xc/H below 35.72 Ohm/m were 3.38 times more likely to develop septic shock in the next day, with a sensitivity of 66.7%, a specificity of 62.3% and AUC of 0.65. PA values below 3.27 had an OR of 9.58 for a septic shock the next day with a sensitivity of 95.8%, specificity of 29.4% and AUC of 0.62. The presence of a value of Xc/H below 33 Ohm/m showed a strong association with the occurrence of septic shock on the same day of the measurement, with an OR of 11.7, as well as a value of PA below 2.64, showed an OR of 14.2.
   Conclusions: The bioelectrical parameters Xc/H and phase angle have limitations in predicting septic shock as isolated biomarkers, but have a potential role as a monitoring tool in the pediatric intensive care unit. The comparative value with other biomarkers remains to be elucidated. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [Almeida de Azevedo, Zina Maria; Salu, Margarida dos Santos; da Luz Caixeta, Daniella Mancino; Lima-Setta, Fernanda; Jacques, Melissa Lorena; Batalha Cox Moore, Daniella Campelo] Fernandes Figueira Inst FIOCRUZ, Inst Nacl Fernandes Figueira, Pediat Dept, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [dos Santos Junior, Braulio] Inst Nacl Cardiol, R Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil.
   [Ramos, Eloane Goncalves; da Fonseca, Vania Mattos; Pedroso, Elza Rosa] Fernandes Figueira Inst FIOCRUZ, Res Dept, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Almeida de Azevedo, Zina Maria; Ramos, Eloane Goncalves; Salu, Margarida dos Santos; da Luz Caixeta, Daniella Mancino; Lima-Setta, Fernanda; Jacques, Melissa Lorena; da Fonseca, Vania Mattos; Pedroso, Elza Rosa; Batalha Cox Moore, Daniella Campelo] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
RP Moore, DCBC (corresponding author), Fernandes Figueira Inst FIOCRUZ, Inst Nacl Fernandes Figueira, Pediat Dept, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.; Moore, DCBC (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
EM zina@iff.fiocruz.br; bsantos@ftml.net; eloanegramos@gmail.com;
   megsalu@yahoo.com.br; daniellamancino@hotmail.com;
   felimasetta@gmail.com; melpelomundo@hotmail.com; vaniamf@iff.fiocruz.br;
   elza@iff.fiocruz.br; daniellamoore@gmail.com
FU Program for the Technological Development in Public Health
   -PDTSP/PROEP-Clinical Research, FIOCRUZ (PROEP/PCLIN Research Tender
   MCT-CNPq/Fiocruz) [03/2012, 402014/20120]
FX This study was supported by the Program for the Technological
   Development in Public Health -PDTSP/PROEP-Clinical Research, FIOCRUZ
   (PROEP/PCLIN Research Tender MCT-CNPq/Fiocruz N degrees 03/2012, process
   402014/20120).
CR Azevedo ZMA, 2013, CLIN NUTR, V32, P824, DOI 10.1016/j.clnu.2013.01.011
   [Anonymous], 1996, AM J CLIN NUTR, V64, p524S
   Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Bustos R, 2015, REV CHIL PEDIATR-CHI, V86, P331, DOI 10.1016/j.rchipe.2015.07.006
   da Silva TK, 2015, NUTR CLIN PRACT, V30, P261, DOI 10.1177/0884533615572150
   De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0
   GARTNER A, 1992, AM J CLIN NUTR, V56, P1067
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Honore PM, 2016, INT J NEPHROL RENOV, V9, P253, DOI 10.2147/IJNRD.S113219
   Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45
   L'Abee C, 2010, CLIN NUTR, V29, P222, DOI 10.1016/j.clnu.2009.08.007
   Lee YH, 2017, J CRIT CARE, V40, P103, DOI 10.1016/j.jcrc.2017.03.013
   Marino LV, 2018, CLIN NUTR, V37, P1430, DOI 10.1016/j.clnu.2017.06.020
   Newson R., 1998, STAT SOFTWARE COMPON
   Newson R., 2004, SENSPEC STATA MODULE
   Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103
   PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305
   POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006
   Prucha M, 2015, CLIN CHIM ACTA, V440, P97, DOI 10.1016/j.cca.2014.11.012
   Savino F, 2003, NUTRITION, V19, P492, DOI 10.1016/S0899-9007(02)00947-4
   Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317
   Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Spanaki AM, 2018, JPEN-PARENTER ENTER, V42, P1061, DOI 10.1002/jpen.1050
   Tanabe RF, 2012, CLIN NUTR, V31, P144, DOI 10.1016/j.clnu.2011.08.006
   Tavladaki T, 2017, PEDIATR CRIT CARE ME, V18, pE494, DOI 10.1097/PCC.0000000000001300
   Vermeulen KM, 2016, NUTR HOSP, V33, P1268, DOI 10.20960/nh.770
   WHO Child Growth Standards, 2006, WEIGHT FOR HEIGHT BO
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 30
TC 0
Z9 0
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD APR
PY 2020
VL 39
IS 4
BP 1188
EP 1194
DI 10.1016/j.clnu.2019.05.005
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA LG1EZ
UT WOS:000527854300025
PM 31153673
DA 2020-12-15
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
   da Cunha, AJLA
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
   Ledo Alves da Cunha, Antonio Jose
TI Prevalence of microcephaly in eight south-eastern and midwestern
   Brazilian neonatal intensive care units: 2011-2015
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
AB Objective To describe the prevalence of microcephaly in infants admitted to the neonatal intensive care units (NICUs) in eight private hospitals in south-eastern and midwestern Brazil, from 2011 to 2015.
   Design Observational, cross-sectional study in a cohort of neonates.
   Setting Eight private NICUs situated in the cities of Rio de Janeiro (RJ), Sao Paulo (SP) and Federal District of Brasilia (FDB).
   Patients Neonates up to 7 days of age and > 23 weeks of gestational age.
   Main outcome measures Primary outcomes were the annual prevalence of microcephaly and severe microcephaly, both overall and in subgroups according to gestational age, type of microcephaly (proportional or disproportional) and the NICU's location in RJ, SP or FDB.
   Results In this cohort of 8275 neonates admitted to eight private NICUs, the overall prevalence of microcephaly was 5.6% (95% CI 5.1% to 6.1%) and severe microcephaly, 1.5% (95% CI 1.2% to 1.7%). There was no annual variation in these overall estimates (p=0.48 and p=0.99, respectively), nor in the studied subgroups. Microcephaly prevalence was higher in extremely premature and term newborns (7.7% and 7.2%; p<0.001, respectively). Disproportional microcephaly was much more common than proportional microcephaly (prevalence 5.0% vs 0.6%; p<0.001).
   Conclusions The prevalence of microcephaly showed little variation from 2011 to 2015 in these south-eastern and midwestern Brazilian NICUs, suggesting that the impact of the Zika epidemic in neonates that occurred mainly in the north-eastern region in 2015 did not yet affect the infants of those regions during the studied period. These prevalence results can serve as a reference for comparisons with any future Zika outbreaks in the same or similar populations from these regions.
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, RJ, Brazil.
   [Lima-Setta, Fernanda] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com
RI Prata-Barbosa, Arnaldo/B-2212-2009; da Cunha, Antonio Jose Ledo
   Alves/O-5914-2019
OI Prata-Barbosa, Arnaldo/0000-0002-4726-9782; da Cunha, Antonio Jose Ledo
   Alves/0000-0003-3592-1849; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Brasil. Ministerio da Saude. Agencia Saude. Microcefalia. Ministerio da Saude divulga boletim epidemiologico, 2015, MICR MIN HLTH PUBL E
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias. Monitoramento de Casos de Microcefalia no Brasil, 2016, 012015 MIN SAUD CTR
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias. Monitoramento de Casos de Microcefalia no Brasil, 2016, 372016 MIN SAUD CTR
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, MIN SAUD SECR VIG SA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha AJLA, 2016, EVOLUTION CASES MICR
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-92
   Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3
   Ministerio da Saude (BR). Departamento de Informatica do SUS (BR), 2014, EST VIT
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rocha HAL, 2016, B WHO
   Soares de Araujo JS, 2016, B WHO
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   WHO, 2016, WHO STAT 2 M IHR EM
   World Health Organization, CHILD GROWTH STAND H
   World Health Organization. Centers for Disease Control and Prevention, 2014, INT CLEAR BIRTH DEF
NR 19
TC 2
Z9 2
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD AUG
PY 2017
VL 102
IS 8
BP 728
EP 734
DI 10.1136/archdischild-2016-311541
PG 7
WC Pediatrics
SC Pediatrics
GA FB0TX
UT WOS:000405858700009
PM 28302630
DA 2020-12-15
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
TI New trends of the microcephaly and Zika virus outbreak in Brazil, July
   2016-December 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo; Lima-Setta, Fernanda] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Cidade Univ,Rua Bruno Lobo,50, BR-21941612 Rio De Janeiro, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com; arnaldoprata@globo.com; jaque.robaina@gmail.com;
   caducer@gmail.com; felimasetta@gmail.com
RI Prata-Barbosa, Arnaldo/B-2212-2009; Raymundo, Carlos/D-3195-2017
OI Prata-Barbosa, Arnaldo/0000-0002-4726-9782; Raymundo,
   Carlos/0000-0001-9615-0991; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Brasil Ministerio da Saude, 2016, MON CAS MICR BRAS IN
   Brasil Ministerio da Saude, BRAS MIN SAUD B EP
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 7
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2017
VL 16
BP 52
EP 57
DI 10.1016/j.tmaid.2017.03.009
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EU6DW
UT WOS:000401125200011
PM 28342826
DA 2020-12-15
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
   da Cunha, AJLA
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
   Ledo Alves da Cunha, Antonio Jose
TI Trends of the microcephaly and Zika virus outbreak in Brazil,
   January-July 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Zika virus; Microcephaly; Congenital abnormalities; Outbreak
AB In the last two months, there have been indications that the Zika virus epidemic is on the decline in Brazil. We reviewed the surveillance data published by the Brazilian Ministry of Health to assess trends of microcephaly and neurological abnormalities suggestive of congenital infection, as well as Zika virus disease in Brazil as a whole and its various regions. From November 2015 to July 2016, 8301 cases of microcephaly were reported in Brazil, mainly in the Northeast region. The number of newly reported cases is declining throughout the country, except in the Southeast region. The numbers of cases that remain under investigation still represent 37.7% of all reported cases in early July. Meanwhile, from January to June, 2016, 165,241 cases of Zika virus disease were reported in Brazil. The state of Rio de Janeiro (South. east) experienced the third highest incidence, lagging behind only the states of Bahia (Northeast) and Mato Grosso (Midwest). In early June, the number of new Zika virus cases showed a marked decline in all of the regions, except the North. Although the Zika epidemic seems to be diminishing, continued monitoring and surveillance of reported microcephaly and neurological abnormality cases is essential, and investigation efforts need to be vastly improved, as some states still reported high incidences of Zika disease in the first half of 2016. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rua Bruno Lobo 50, BR-21941612 Rio De Janeiro, RJ, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com; arnaldoprata@globo.com; jaque.robaina@gmail.com;
   caducer@gmail.com; felimasetta@gmail.com; acunha@hucff.ufrj.br
RI Raymundo, Carlos/D-3195-2017; Prata-Barbosa, Arnaldo/B-2212-2009; da
   Cunha, Antonio Jose Ledo Alves/O-5914-2019
OI Raymundo, Carlos/0000-0001-9615-0991; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; da Cunha, Antonio Jose Ledo
   Alves/0000-0003-3592-1849; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Brasil. Ministerio da Saade, 012015 MIN SAUD SECR
   Brasil. Ministerio da Saiide, 2016, 332016 MIN SAUD CTR
   Brasil. Ministerio da SaOcle, MIN SAUD B EP
   Brasil. Ministerio da SaOde, 2016, 012015 MIN SAUD CTR
   Brasil. Ministerio da SaOde, 2016, PROT VIG RESP OC MIC
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha AJLA, 2015, B WHO, V16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   WHO, 2016, ZIK STRAT RESP FRAM
NR 9
TC 24
Z9 24
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 458
EP 463
DI 10.1016/j.tmaid.2016.09.006
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300007
PM 27702683
DA 2020-12-15
ER

EF